On ECHEMI
Home > Drugs > XI'AN HAIXIN Pharmaceutical Co., Ltd.

XI'AN HAIXIN Pharmaceutical Co., Ltd.

  • Founded in:

    1995-09-22
  • Country:

    China China
  • Address:

    No. 20, Tuanjie South Road, Xi'an High-tech Development Zone
  • Tax NO.:

    916101312944622939
  • Registered Funds:

    $15 million
  • Website:

  • Email:

Related Drugs
Metformin and Glibenclamide Tablets (Ⅰ)
This product is a compound preparation, each tablet containing 1.25 mg of glibenclamide and 250 mg of metformin hydrochloride.
Name Description Content CAS NO. Registered Holders
Glibenclamide

Hypoglycemic effect by stimulating pancreatic beta cells to secrete insulin

More

Hypoglycemic effect by stimulating pancreatic beta cells to secrete insulin

1.25mg 10238-21-8 28
1,1-DIMETHYLBIGUANIDE HYDROCHLORIDE

It can reduce the production of glycogen in the liver, reduce the intestinal absorption of sugar, and can stimulate the pancreatic beta cells to secrete insulin to produce a blood sugar-lowering effect

More

It can reduce the production of glycogen in the liver, reduce the intestinal absorption of sugar, and can stimulate the pancreatic beta cells to secrete insulin to produce a blood sugar-lowering effect

250mg 15537-72-1 55
Aniracetam
Name Description Content CAS NO. Registered Holders
Aniracetam

Not clearly described

More

Not clearly described

72432-10-1 11
Erdosteine Capsules
The main ingredient is erdosteine.
Name Description Content CAS NO. Registered Holders
9-Chloro-2-methyl-5H-pyrazolo[1,5-d][1,4]benzodiazepin-6(7H)-one

This product is a mucolytic agent and a prodrug. Its molecular structure contains a blocked thiol group (-SH). It is transformed into an active metabolite containing free thiol groups through liver biotransformation to play a mucolytic role. Its mechanism of action may be mainly to break the disulfide bonds of mucin in bronchial secretions through metabolites containing free thiol groups, change its composition and rheological properties (reduce sputum viscosity), and thus facilitate sputum discharge. In addition, this product also has the effect of enhancing the function of mucociliary function.

More

This product is a mucolytic agent and a prodrug. Its molecular structure contains a blocked thiol group (-SH). It is transformed into an active metabolite containing free thiol groups through liver biotransformation to play a mucolytic role. Its mechanism of action may be mainly to break the disulfide bonds of mucin in bronchial secretions through metabolites containing free thiol groups, change its composition and rheological properties (reduce sputum viscosity), and thus facilitate sputum discharge. In addition, this product also has the effect of enhancing the function of mucociliary function.

84661-23-4 5
Erdosteine Capsules
(±)-N-[2-[(Carboxymethylthio)-acetyl]-homocysteine thiolactone
Name Description Content CAS NO. Registered Holders
Erdosteine

This product is a mucolytic agent and a prodrug. It is transformed into active metabolites containing free sulfhydryl groups by the liver to dissolve mucosmetic phlegm. Its mechanism of action may be mainly to break the disulfide bonds of mucin in bronchial secretions through metabolites containing free sulfhydryl groups, change its composition and rheological properties (reduce sputum viscosity), and thus facilitate sputum discharge. In addition, this product also has the effect of enhancing the function of mucociliary function.

More

This product is a mucolytic agent and a prodrug. It is transformed into active metabolites containing free sulfhydryl groups by the liver to dissolve mucosmetic phlegm. Its mechanism of action may be mainly to break the disulfide bonds of mucin in bronchial secretions through metabolites containing free sulfhydryl groups, change its composition and rheological properties (reduce sputum viscosity), and thus facilitate sputum discharge. In addition, this product also has the effect of enhancing the function of mucociliary function.

84611-23-4 0
Erdosteine
Name Description Content CAS NO. Registered Holders
9-Chloro-2-methyl-5H-pyrazolo[1,5-d][1,4]benzodiazepin-6(7H)-one

Extract from the above information

More

Extract from the above information

84661-23-4 5
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.